Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| U01CE003825 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Centers for Disease Control and Prevention | FED |
Not provided
Not provided
Not provided
Not provided
The purpose of this research study is to learn if an emergency department screening and telehealth intervention reduces substance use among individuals receiving emergency department treatment at The Ohio State University Wexner Medical Center.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ED-SMART intervention | Experimental | The ED-SMART intervention includes: (i) a brief (approximately 15 minutes) counseling session in the emergency department and (ii) five, monthly brief counseling sessions (approximately 15 to 30 minutes) delivered by telehealth. These sessions will focus on creating individualized strategies to help participants reach their alcohol and substance use reduction goals. |
|
| Substance use information | Placebo Comparator | The substance use information condition will receive printed health information covering information about substance use (e.g., definitions, hazards, potential for addiction, injury, and other consequences). Staff will also discuss ways to utilize primary care or establish care with a primary care provider to provide ongoing follow-up. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ED-SMART intervention | Behavioral | The ED-SMART intervention will include: (i) a brief (approximately 15 minutes) counseling session in the emergency department and (ii) five, monthly brief counseling sessions (approximately 15 to 30 minutes) delivered by telehealth. These sessions will focus on creating individualized strategies to help participants reach their alcohol and substance use reduction goals |
| Measure | Description | Time Frame |
|---|---|---|
| Self-reported substance use | Self-reported substance use frequency | From baseline to the sixth month follow-up assessment |
| Measure | Description | Time Frame |
|---|---|---|
| Self-reported substance use quantity | Self-reported substance use quantity for each substance | From baseline to the six month follow-up |
| Incidence of positive substance use disorder screen | Incidence of positive substance use disorder screen as measured by the NIDA Modified ASSIST or AUDIT |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jennifer L Brown, PhD | Contact | 866-818-2620 | jenniferbrown@purdue.edu |
| Name | Affiliation | Role |
|---|---|---|
| Jennifer L. Brown, PhD | Purdue University | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Substance use information | Behavioral | The substance use information condition will receive printed health information covering information about substance use (e.g., definitions, hazards, potential for addiction, injury, and other consequences). Research staff will also discuss ways to utilize primary care or establish care with a primary care provider to provide ongoing follow-up. |
|
| From baseline to the six month follow-up |
| Toxicology assays for substance use | Proportion with positive toxicology assay for substance use | From baseline to the six month follow-up assessment |
| Self-reported healthcare utilization | Self-reported healthcare utilization | Baseline to the six month follow-up assessment |
| Fatal and non-fatal overdose | Frequency of fatal and non-fatal overdose | Baseline to the six month follow-up assessment |
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| ID | Term |
|---|---|
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided